Therapeutic Innovation in Type 2 DIABetes (IT-DIAB) (IT-DIAB)

This study is ongoing, but not recruiting participants.

Sponsor:

Nantes University Hospital

ClinicalTrials.gov Identifier:

NCT01218061

First Posted: October 11, 2010

Last Update Posted: June 16, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The main objective of the study is to follow prospectively a cohort of patients with pre-diabetes to understand the pathophysiological mechanisms involved in switching from pre-diabetes to type 2 diabetes and to identify new biomarkers of type 2 diabetes risk in this population.

The main objective of the study is to understand the pathophysiological mechanisms involved in switching from pre-diabetes to type 2 diabetes and to identify new biomarkers of type 2 diabetes risk in this population [ Time Frame: 10 years ]

The main objective of the study is to follow prospectively a cohort of patients with pre-diabetes to understand the pathophysiological mechanisms involved in switching from pre-diabetes to type 2 diabetes and to identify new biomarkers of type 2 diabetes risk in this population

Secondary Outcome Measures:

Number of patients with pre-diabetes [ Time Frame: 10 years ]

To evaluate the prevalence of pre-diabetes in the region of Nantes

HbA1c measurement [ Time Frame: 10 years ]

To evaluate the role of HbA1C in screening for pre-diabetes and T2D

Number of patients with high Diabetes Risk Score and pre-diabetes [ Time Frame: 10 years ]

To evaluate the interest of the Diabetes Risk Score in identifying subjects with pre-diabetes in the French population

Number of patients with others cardiovascular risk factors [ Time Frame: 10 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.